Replies to post #99186 on Protagenic Therapeutics Inc. (PTIX)

[Senorita Roachita]

ATRN is actually worth more without Kaaza dragging them down. BRB liscensing fees, BRB can't compete with iTunes.

Who cares about Kaaza anyways? It's not ATRN's problem anymore and the market reacted positively to the sale of Kaaza.